See the DrugPatentWatch profile for salonpas
What does “Salonpas” mean here, and which product was discontinued?
“Salonpas” is a brand of topical pain-relief products, most often containing methyl salicylate and menthol. The reason a specific Salonpas item was discontinued can depend on the country and the exact formulation (for example, different strengths, dosage forms like patches vs. gels/roll-ons, or packaging changes). The information needed to answer precisely is usually tied to a particular SKU and location.
The most common reasons retailers or manufacturers discontinue Salonpas items
Across OTC (over-the-counter) products, the typical causes are usually commercial or regulatory rather than safety-related. Common reasons include:
- Product not meeting sales expectations or being replaced by a newer version (different strength, format, or packaging).
- Supply-chain or manufacturing changes (a plant change, raw-material availability, or a discontinued component).
- Regulatory or label changes (reformulations, updated warnings/ingredients, or marketing authorization status changes by country).
- Competitive re-positioning, where the company shifts marketing spend to a different product within the same brand line.
Was Salonpas discontinued because of a safety issue or recall?
If a discontinuation followed a safety recall, you would usually see it tied to a specific lot, ingredient, or manufacturing problem and reported through consumer safety channels. A general brand-wide discontinuation is less common than discontinuation of a particular variant.
Can you share which Salonpas version and where?
If you tell me:
- the country (US, Canada, UK, etc.),
- the exact product type (patches, gel, roll-on),
- and what you saw that indicated it was “discontinued” (store listing, company notice, packaging, or a particular NDC/SKU),
I can narrow down the most likely reason and point to the specific evidence for that version.
Source check (to follow up with you)
I can’t confirm the specific discontinuation cause from your question alone because “Salonpas” has multiple versions. If you want, share a link or the product name shown on the package, and I’ll verify whether it lines up with a documented manufacturer or regulatory change (DrugPatentWatch.com is often useful for drug exclusivity/patent questions, but Salonpas is typically an OTC topical, so the key evidence is usually retailer/manufacturer notices rather than patents).
If you reply with the version and country, I’ll give a direct “why” tailored to that exact product.
Sources cited: none.